JosephHButterfieldMD
Allergy & Immunology • Rochester, MNProfessor, Internal Medicine, Mayo Medical School
Are you Dr. Butterfield?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 34 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
200 1st St SW
Rochester, MN 55905Phone+1 507-284-2511
Summary
- Dr. Joseph Butterfield, MD is an allergist/immunologist in Rochester, Minnesota. He is currently licensed to practice medicine in Minnesota. He is affiliated with Mayo Clinic Hospital - Rochester and is a Professor at Mayo Medical School.
Education & Training
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1974
Certifications & Licensure
MN State Medical License 1979 - 2025- American Board of Allergy and Immunology Allergy & Immunology
- American Board of Internal Medicine Internal Medicine
Clinical Trials
- Use of Tamoxifen in Systemic Mastocytosis Start of enrollment: 2005 Feb 01
- Topical Composition Therapy for the Treatment of Cutaneous Mastocytosis Start of enrollment: 2021 Jul 26
Publications & Presentations
PubMed
- 1 citationsHarmonization of Diagnostic Criteria in Mastocytosis for Use in Clinical Practice: WHO vs ICC vs AIM/ECNM.Peter Valent, Karin Hartmann, Gregor Hoermann, Andreas Reiter, Iván Alvarez-Twose
The Journal of Allergy and Clinical Immunology. in Practice. 2024-12-01 - Mast cell activation syndrome: Current understanding and research needs.Mariana Castells, Matthew P Giannetti, Matthew J Hamilton, Peter Novak, Olga Pozdnyakova
The Journal of Allergy and Clinical Immunology. 2024-08-01 - Metformin: A potential adjunct for treatment of systemic mastocytosis.Joseph H Butterfield, Kathleen Bartemes
The Journal of Allergy and Clinical Immunology. Global. 2024-02-01
Press Mentions
First Edition: July 24, 2020July 24th, 2020
Apgar ScoreNovember 4th, 2018
Grant Support
- Low Dose Mithramycin Treatment Of Bone Pain In Systemic MastocytosisNational Center For Research Resources1999
- Intron-A (Interferon Alfa-2b) In Systemic MastocytosisNational Center For Research Resources1994–1995
- Intron A (Interferon Alpha-2b) In Hypereosinophilic SyndromeNational Center For Research Resources1993–1994
- Eosinophil Colony Forming Cells In Eosinophilic DiseasesNational Institute Of Allergy And Infectious Diseases1985
